Figure S8 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity

Figure S8 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity

<p>Figure S8R</p>

Furkejuvvon:
Bibliográfalaš dieđut
Váldodahkki: Shiyi Yu (17079079) (author)
Eará dahkkit: Ying Wang (17079082) (author), Xue Gong (17079085) (author), Zhehao Fan (17079088) (author), Zheng Wang (17079091) (author), Zhengyan Liang (17079094) (author), Rui Wu (17079097) (author), Binjie Cao (17079100) (author), Ning Wang (17079103) (author), Caili Bi (17079106) (author), Dan Lv (17079109) (author), Haibo Sun (17079112) (author)
Almmustuhtton: 2025
Fáttát:
Cancer
Molecular and Cellular Biology
Therapeutic Research and Development
Breast Cancer
Cell Cycle
Signal transduction pathways
Drug Resistance
Regulation of gene expression in drug resistance
Endocrine-Related Cancers
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
Govvádus
Čoahkkáigeassu:<p>Figure S8R</p>

Geahča maid